🔗 Gravitee: The API platform unifying AI agents, event streams, and legacy systems

Gravitee has secured $60 million in Series C funding to expand its Agentic API and Event Management platform, addressing the growing complexity of modern digital infrastructures.

🧩 Unified control for modern architectures
• Combines management of APIs, AI agents, and event streams into a single platform
• Supports both synchronous (REST) and asynchronous (event-driven) communications
• Enhances security, observability, and governance across hybrid systems

📈 Scaling with enterprise demand
• Trusted by global brands like Michelin, Roche, and Blue Yonder
• Recognized as a leader in Gartner’s Magic Quadrant for API management
• Included in Tech Nation’s 2025 Future Fifty list

🛸 Open-source roots, enterprise focus
• Founded in 2015 by a team of developers aiming to simplify API management
• Offers both open-source tools and enterprise-grade solutions
• Provides deployment flexibility: on-premises, self-hosted, or SaaS

💰 Backed by strategic investors
• $60M Series C led by Sixth Street Growth, with participation from Riverside Acceleration Capital and AlbionVC
• Total funding exceeds $125 million
• Sixth Street’s Michael Bauer joins the board to support global expansion

As enterprises integrate AI agents and event-driven architectures, Gravitee’s unified platform positions it to become an essential tool for managing the complexities of modern digital systems.

📊 Powered by V3V Ventures

🌐 Airwallex: Building the financial backbone for global businesses

Airwallex has secured a $300 million Series F funding round, elevating its valuation to $6.2 billion. The round includes $150 million in secondary share sales and features investors such as Visa Ventures, Salesforce Ventures, Square Peg, DST Global, Lone Pine Capital, Blackbird, Airtree, and several large Australian pension funds.

✅ Key highlights of the funding round
• Total funding raised: $300 million, with $150 million in secondary share sales
• Valuation: $6.2 billion
• Notable investors: Visa Ventures, Salesforce Ventures, Square Peg, DST Global, Lone Pine Capital, Blackbird, Airtree, and several large Australian pension funds
• Total funding to date: Over $1.2 billion
• Employee count: Over 1,700 across 26 offices globally

🌎 Strategic expansion plans
• Targeting new markets: Japan, Korea, the UAE, and Latin America
• Enhancing go-to-market teams in North America, Europe, and Southeast Asia
• Recent expansions include a permanent U.S. headquarters in San Francisco, new offices in New York and Toronto, and operations in Latin America, including a soon-to-launch service in Brazil and the acquisition of Mexican payment firm MexPago.

📈 Business growth and performance
• Annual revenue run rate: On track to surpass $1 billion in 2025, up from $720 million as of March
• Gross profit CAGR: Over 250% across the Americas and Europe over the past four years
• Customer base: Over 150,000 businesses, including Brex, BILL, Deel, Rippling, Navan, and Qantas
• Customer growth: 50% increase in 2024

⚙️ Platform capabilities
• Services: Global business accounts, multicurrency cards, embedded finance APIs
• Transaction processing: Enables fund transfers across more than 150 countries, with 68% of transactions processed instantly and 95% arriving within hours
• Infrastructure: Built direct integrations with local clearing systems and card networks in over 60 countries

With this significant funding and strategic partnerships, Airwallex is poised to redefine global banking infrastructure, empowering businesses to operate seamlessly across borders.

📊 Powered by V3V Ventures

🧠 Zoca: Agentic AI for the neighborhood economy

Zoca just raised $6M from Accel to give local service businesses AI agents that handle growth—from lead generation to repeat bookings—with zero marketing expertise required.

🎯 Built for local dominance
• AI agents automate ads, websites, rebooking, and follow-ups
• Hyperlocal demand intelligence tailors outreach by zip code
• Integrates with tools like Google Business, Fresha, Vagaro for full-stack control

🚀 Quiet traction in service SMBs
• Over 1,000 local businesses onboarded since 2024
• 120,000+ bookings driven, $10M+ in client revenue generated
• Customers save hours each week on marketing and ops

🧠 Founders with technical firepower
• Ashish Verma (ex-Fortune 500 AI lead) and Robin Chauhan (ex-unicorn data infra)
• Both IIT Kharagpur grads with firsthand insight into SMB tech gaps
• Building Zoca as the AI-native OS for hyperlocal services

💸 Backed by early-stage winners
• $6M seed led by Accel, joined by GTMfund, Elevation Capital, Better Capital
• Funds to scale engineering, expand verticals, and grow AI agent capabilities
• First targets: beauty, wellness, dental, pet care—fragmented but high-LTV

Zoca is betting that the next big AI platform won’t serve enterprises—it’ll serve your neighborhood.

📊 Powered by V3V Ventures

⚡️ Crusoe: The energy-to-AI pivot building OpenAI’s $15B supercomputer

Crusoe Energy just raised a massive $11.6B to build what will be OpenAI’s largest compute hub—transforming Abilene, Texas into a global capital for AI infrastructure.

⚙️ Rewiring infrastructure for AI scale
• Eight-building data center campus powered by 1.2 GW of energy
• Up to 400,000 Nvidia Blackwell GPUs deployed across the site
• Designed to support frontier model training at exascale levels

🔥 From stranded gas to sovereign AI stacks
• Crusoe started in crypto, using flared gas to power data centers
• Now pivoted fully to AI infrastructure—powering OpenAI, Oracle, and others
• Combines gas, wind, and solar for flexible energy sourcing

🤝 Anchored by deep alliances
• OpenAI and Oracle co-leading “Project Stargate,” Crusoe’s hyperscale rollout
• Oracle has signed a 15-year lease to deliver OpenAI’s dedicated cloud layer
• SoftBank and MGX also involved in funding and infrastructure

🌎 National scale, local impact
• Thousands of new construction and tech jobs for West Texas
• Liquid and air cooling systems for sustainability at GPU scale
• Scheduled to come online by 2026, setting a new bar for AI buildouts

Crusoe isn’t just building data centers, it’s reshaping the industrial backbone of the AI era.

📊 Powered by V3V Ventures

🛸 Siro: The AI sales coach transforming door-to-door performance

Siro is redefining how field sales teams learn and close—using real conversation data to drive 36% better close rates. Now with $50M from SignalFire, it’s taking AI coaching mainstream.

🎯 Precision coaching from real conversations
• Mobile app captures live, in-person sales pitches
• Converts voice into structured data for coaching insights
• Helps reps improve faster and managers coach more effectively

📈 Sales teams feel the impact
• 36% higher close rates and 30% lower rep turnover
• Coaching cycles are 10x faster—turning daily activity into daily improvement
• Stories include reps breaking sales records and managers reclaiming family time

🛸 Founder with field grit
• CEO Jake Cronin started selling Cutco knives door-to-door
• Built Siro to give field reps the same tech leverage as SaaS teams
• Emphasizes human-first coaching enhanced—not replaced—by AI

💰 Big capital to scale smart
• $50M Series B led by SignalFire, with backing from existing investors
• Total funding now $75M, fueling adaptive coaching and real-time team visibility
• Expanding across product, engineering, and go-to-market

Siro isn’t another AI assistant—it’s a full-stack performance system for the people still knocking on doors.

📊 Powered by V3V Ventures

🟣RevenueCat: The monetization engine powering 50,000+ apps—and now expanding beyond subscriptions

RevenueCat has raised a $50 million Series C round led by Bain Capital Ventures, bringing its total funding to $100 million. The company now powers over one-third of all new subscription apps globally and is expanding into virtual currencies, fintech tools, and web monetization.

🎯 Built for modern app monetization
• Manages subscriptions, in-app purchases, consumables, and virtual currencies
• Offers tools like Paywalls (drag-and-drop editor), Experiments, and Customer Center
• Supports Web Billing and external payment flows, helping developers reduce platform fees

📈 Scaling with the app economy
• Over 50,000 apps use RevenueCat, including ChatGPT, Notion, VSCO, and Runna
• New app integrations have more than doubled in the past six months, driven by AI and gaming
• Processes billions in payments annually

🛸 Founder with developer empathy
• CEO Jacob Eiting co-founded RevenueCat in 2017 to simplify app monetization
• Focused on helping developers get paid and navigate complex monetization challenges
• Aims to build a public-scale company that supports the evolving needs of app developers

💰 Backed by top-tier investors
• $50M Series C led by Bain Capital Ventures, with participation from Index Ventures, Y Combinator, Adjacent, Volo Ventures, and SaaStr Fund
• Post-money valuation of $500 million

RevenueCat is evolving from a subscription management tool to a comprehensive monetization platform, addressing the diverse needs of modern app developers.

📊 Powered by V3V Ventures

👀 Worldcoin: Sam Altman’s crypto ID project scans your eyes for a shot at universal digital identity

Worldcoin is betting big on biometric proof of personhood—using iris scans to issue a “World ID” and distribute free crypto. With $135M in fresh funding, it’s expanding fast across 20 countries.

🎯 Orb-scanned identity, encrypted by design
• Users scan their iris via a silver “Orb” to receive a unique, anonymous World ID
• Claims biometric data is immediately deleted post-verification
• Aims to differentiate real humans from bots in an AI-dominated digital world

🌎 Global rollout with local incentives
• Over 2M users onboarded across 35 cities since beta
• Free Worldcoin tokens (WLD) offered to verified users
• Storefront “orbing” sites live in SF, Miami, and beyond

🗣️ A bold vision from OpenAI’s founder
• Co-founded by Sam Altman, focused on identity in the AI age
• Sees World ID as a foundation for democratic tools, fintech, and digital governance
• Facing resistance over privacy, but pushing ahead on global infrastructure

💰 Backed to scale the Orb network
• $135M raised from a16z, Bain Capital Crypto, and others
• Funds support a U.S. expansion to 7,500 Orbs by year-end
• Valuation rumored in the high hundreds of millions

Worldcoin is more than just a crypto giveaway—it’s a high-stakes bet on the future of identity in an increasingly automated world.

📊 Powered by V3V Ventures

🦏 Rhino: The federated AI startup enabling secure data collaboration across industries

Rhino has raised $15M to scale its enterprise-grade federated learning platform—powering AI collaboration without compromising on data privacy, compliance, or ownership.

🎯 Built for regulated industries
• Trains AI across siloed datasets without moving or centralizing data
• Ensures full compliance with HIPAA, GDPR, and other strict privacy laws
• Tailored for healthcare, biopharma, and financial services use cases

🚀 Real-world traction with real-world data
• Powering AI drug discovery via FAITE Biopharma Consortium partnerships
• Enabling secure data sharing at Sheba Medical Center in Israel
• Teaming with Swift and Google to tackle fraud in financial transactions

🛸 Founded by experts who’ve been there
• CEO Dr. Ittai Dayan was AI lead at Mass General Brigham and a Harvard-trained researcher
• Co-founder Yuval Baror has built enterprise AI systems for two decades
• Team deeply embedded in both clinical and technical communities

💰 Funded to go global
• $15M Series A led by AlleyCorp, joined by LionBird, Fusion Fund, and others
• Total funding now over $30M to scale product, GTM, and key partnerships
• Focused on expanding federated learning adoption across the U.S. and Europe

Rhino isn’t just a privacy layer—it’s a strategic infrastructure bet for any sector where AI matters but data can’t move.

📊 Powered by V3V Ventures

🦴 Butternut Box: The fresh dog food startup turning Europe into its backyard

Butternut Box is redefining pet nutrition with made-to-order meals for dogs—and now it’s fetched over €75M from Liquidity Group to scale across Europe and cement its unicorn status.

🐶 Built for pet wellness
• Fresh, human-grade meals tailored to each dog’s needs
• Transparent sourcing, low-temperature cooking to preserve nutrients
• Over 10 vet-reviewed recipes—now expanding into cat food with new brand, Marro

📦 Scaling across the continent
• Already active in UK, Ireland, Benelux, Germany, and Poland
• New capital will boost production capacity and unlock new EU markets
• Investment supports logistics, tech stack, and pet parent experience

🧠 Led by dog-first founders
• Co-founders Kevin Glynn and David Nolan created the brand after frustrations with processed pet food
• Obsessed with retention and customer delight—think “HelloFresh for dogs”
• Built a strong team culture around care, quality, and mission-driven growth

💰 Backed by smart capital
• €75M+ in structured equity from Liquidity Group—non-dilutive and fast-moving
• Adds to previous funding from L Catterton, Five Seasons, and Passion Capital
• Positioned to dominate Europe’s fast-growing fresh pet food market

Butternut Box isn’t just chasing tails—it’s building the next category-defining pet wellness brand in Europe.

📊 Powered by V3V Ventures

🟣 Throne: The AI-powered toilet transforming gut health monitoring

Throne, an Austin-based startup, is revolutionizing personal health tracking with its AI-powered toilet-mounted device. Having secured $4 million in seed funding led by Moxxie Ventures, Throne aims to bring clinical-grade gut health insights into homes.

🧠 Innovative health monitoring
• Utilizes computer vision and AI to analyze waste for signs of chronic conditions, hydration levels, and urological health.
• Designed as a discreet device that mounts onto existing toilets, ensuring user comfort and privacy.
• Incorporates privacy controls, anonymizing images before analysis.

🚀 From concept to prototype
• Originated from a lighthearted poker night idea between co-founders Scott Hickle and Tim Blumberg.
• Transitioned from a failed nurse-hiring software venture to developing a health-focused device.
• Currently in pre-production, with a planned launch in January 2026.

👩‍⚕️ Expert leadership
• CEO Scott Hickle brings mechanical engineering expertise.
• CTO Tim Blumberg contributes full-stack software development experience.
• John Capodilupo, former WHOOP CTO, joins as Chief Product Officer, enhancing the team’s health tech credentials.

💰 Strategic funding
• $4 million seed round led by Moxxie Ventures’ Katie Jacobs Stanton.
• Notable angel investors include Lance Armstrong, Rupa Health co-founder Tara Viswanathan, and TrueMed founder Justin Mares.

Throne is poised to redefine at-home health diagnostics, offering users unprecedented insights into their gut health through innovative technology.

📊 Powered by V3V Ventures

🤖 DiffuseDrive: The data engine powering next-gen robotics

Training robots isn’t just about better models—it’s about better data. DiffuseDrive is building the platform to collect, label, and scale high-quality real-world data, now with $3.5M from top-tier backers.

🎯 Solving robotics’ real bottleneck
• Provides AI-native tooling to capture and label real-world robotic interactions
• Optimized for long-tail edge cases traditional pipelines miss
• Cuts human labeling time with automated, scalable annotation workflows

🚀 From lab demos to warehouse floors
• Already used by stealth robotics startups in logistics and mobility
• Supports integration with both simulators and physical robots
• Accelerates feedback loops from deployment back into model training

🧠 Engineered by experts in autonomy
• Founded by ex-Meta and Waymo engineers with deep robotics experience
• Tackling problems they saw firsthand in scaling physical AI systems
• Mission-driven to make embodied AI as trainable as LLMs

💰 Backed by YC and early believers
• $3.5M seed led by Pioneer Fund, with Liquid 2, Soma Capital, and YC
• 25+ investors joining to back infrastructure for the physical AI wave
• Positioning as the Scale AI for the real world

DiffuseDrive isn’t building robots—it’s making it possible to teach them at scale.

📊 Powered by V3V Ventures

🩺 General Medicine: The PillPack founders are back, this time to fix primary care

After reshaping pharmacy with PillPack (acquired by Amazon for $750M), TJ Parker and Elliot Cohen are launching General Medicine, a new marketplace to make accessing medical care feel as seamless as online shopping.

🛒 Healthcare, meet e-commerce design
• Lets patients book care from independent clinicians with transparent pricing
• Designed to handle common needs: infections, skin issues, birth control, labs, more
• Focused on asynchronous, fast-access care, no video calls or waiting rooms

📦 Built for scale, not clinics
• No physical locations, 100% virtual marketplace model
• Clinicians can set their own hours and prices; patients choose based on clarity and speed
• Launching with 50+ licensed providers across multiple states

🧠 A repeat team with delivery DNA
• TJ and Elliot scaled PillPack from startup to $750M Amazon exit
• Deep experience in healthcare logistics, consumer UX, and regulatory complexity
• Their new goal: abstract away the messy front end of medicine

💰 Backed by a strong cap table
• Seed round raised quietly investors not yet disclosed
• Reinvesting their PillPack learnings to build a platform, not a provider
• Early focus on product-led growth and user trust over blitz-scaling

General Medicine wants to make medical care as intuitive and fast as adding to cart.

📊 Powered by V3V Ventures

🎁 Awardco: Reinventing Employee Rewards with an Amazon-Style Experience

Awardco, a Utah-based startup, just raised $165M in Series B funding led by Sixth Street Growth—pushing its valuation past $1B. Its mission? To modernize employee recognition with a flexible, e-commerce-like platform.

🛍️ Recognition, reimagined
• Helps companies design personalized, global reward programs
• Employees earn points redeemable via Amazon, Lazada, and more
• Tackles disengagement by making recognition frequent, relevant, and easy

🏢 From the office to the arena
• Trusted by AT&T, McDonald’s, Hertz, and Dow Jones
• Expanding into performance incentives and fan engagement
• Partners include Smith Entertainment Group and the Utah Jazz

🚀 Platform-first, global by design
• 100% digital, scalable across traditional, hybrid, and remote workforces
• Revenue from annual subscriptions and licenses
• Positioned as the “Amazon of rewards”—focused on variety and user control

🧠 Founder-led and repeat-backed
• Bootstrapped for years before taking its first funding in 2021
• Backers include Spectrum Equity and General Catalyst
• Building a long-term system for retention, not just perks

Awardco is betting that in the future of work, meaningful recognition will matter as much as salary.

📊 Powered by V3V Ventures

🌱 Alt Carbon: Transforming India’s Farmlands into Carbon Sinks

Alt Carbon, a climate-tech startup founded by siblings Shrey and Sparsh Agarwal, has secured $12 million in seed funding led by Lachy Groom. The company aims to scale its carbon dioxide removal efforts across India using enhanced rock weathering (ERW) techniques .

🍃 Harnessing Nature for Carbon Removal
• Utilizes waste basalt rock dust from India’s Rajmahal Traps, spreading it on agricultural lands.
• The basalt reacts with rainwater and atmospheric CO₂, forming stable bicarbonate ions that eventually become calcium carbonate, locking away carbon for over 10,000 years.
• This process not only sequesters carbon but also enriches soil fertility, benefiting crops like tea, rice, and bamboo .

🍃 From Tea Estate to Climate Innovation
• The Agarwal brothers’ journey began in 2020 when they returned to their family’s struggling tea estate in Darjeeling.
• Their exploration into carbon markets led to the discovery of ERW as a viable solution for both climate action and agricultural revitalization.
• Alt Carbon officially launched in late 2023, piloting their technology on 500 acres of tea farmland and expanding to other crops in North Bengal .

📈 Ambitious Goals for a Greener Future
• Targets to expand operations to 500,000 hectares of land by 2030.
• Aims to remove 5 million tons of CO₂ from the atmosphere within the same timeframe.
• Plans to invest in Earth Sciences R&D and advanced hardware to support scalable and durable climate action in the Global South .

💡 Innovative Approach to Carbon Markets
• Alt Carbon’s method addresses concerns over low-quality, avoidance-based carbon credits prevalent in India.
• By focusing on removal-based credits through ERW, the company offers a more permanent and verifiable solution for carbon sequestration.
• Their flagship initiative, The Darjeeling Revival Project, aims to unite climate action with cultural and ecological restoration .

Alt Carbon’s approach not only contributes to global carbon reduction efforts but also supports local farming communities, making it a promising model for sustainable development.

📊 Powered by V3V Ventures

🧬 Signatur Biosciences: Bringing Precision Breast Cancer Diagnostics to the Point of Care

Signatur Biosciences, a London-based startup, has raised $7 million in seed funding to develop and validate OncoSignatur Breast (OSB), a decentralized breast cancer prognostic test designed for use in local hospitals and clinics.

🔬 OncoSignatur Breast: Decentralizing Precision Diagnostics
• OSB is a decentralized breast cancer prognostic test under development.
• Designed to be run directly in local hospitals and clinical labs using standard qPCR machines.
• Delivers same-day results, reducing costs and enabling healthcare providers to retain testing revenue.
• Powered by PCRchitectur, Signatur’s proprietary technology that condenses complex testing workflows into a single qPCR reaction.
• Reduces material costs by up to 20-fold compared to conventional methods.

💰 Funding and Strategic Expansion
• The $7 million seed round brings total funding to $9.9 million through a mix of equity and grants.
• Funding will be used to finalize and validate OSB, establish a dedicated laboratory in Liège, Belgium, and expand the scientific and operational team.
• The move to Liège, facilitated by investor Noshaq, positions the company within a rapidly expanding European biotech ecosystem.

👥 Founders with a Vision for Accessible Diagnostics
• Founded in 2022 by bioengineers Celestin de Wergifosse and Dr. John Goertz, with scientific leadership from Prof. Dame Molly Stevens.
• The team aims to create decentralized, cost-effective molecular tests that can run on standard qPCR machines, making advanced diagnostics globally accessible.

Signatur Biosciences is working to make precision medicine local, fast, and accessible to all by decentralizing diagnostic capabilities and empowering clinicians and patients with timely, informed treatment decisions.

📊 Powered by V3V Ventures

🔨 WakeCap: Real-time worker data is transforming construction in Saudi Arabia

WakeCap, a Saudi startup digitizing construction sites with smart helmets and real-time labor data, has raised $28M in Series A funding to expand globally and bring more AI into site operations.

🔺 Sensors, not spreadsheets
• WakeCap installs IoT sensors in worker helmets to track attendance, location, and safety
• Integrates with existing workflows—no phones or manual input required
• Real-time dashboard for contractors to monitor labor flow, incident response, and productivity

📊 Built for megaprojects
• Already deployed on $80B+ worth of construction sites, including Aramco, NEOM, and Qiddiya
• Over 150M worker hours tracked to date
• Key metrics: 91% fewer safety incidents, 25% higher productivity, 70% faster emergency response

🌍 Funding to go global
• $28M Series A led by UP.Partners, joined by Graphene Ventures and strategic investors
• Will expand across Saudi, UAE, U.S., and Japan
• Plans to deepen integrations with ecosystem players like Oracle and OpenSpace

🔩 Founders with industry insight
• Founded by Dr. Hassan Albalawi and Ishita Sood in 2017
• Team blends construction, hardware, and AI expertise
• Vision: build the “connected jobsite” with scalable, non-intrusive technology

WakeCap is turning hard hats into hubs for data—making labor visibility a default, not an afterthought.

📊 Powered by V3V Ventures

🏭 Evolution Fund: Backing Scaleups in the UK’s Industrial Heartland

The British Business Bank is injecting £40M into Frontier Development Capital’s £81.5M Evolution Fund to fuel established SMEs across the Midlands and North—regions often left behind in the VC race.

💳 Flexible funding for serious scale
• Offers debt deals between £1M–£8M for mature, growing businesses
• Designed for buyouts, acquisitions, shareholder restructures, and scale-up capital
• Targets companies with strong fundamentals and regional roots

🌱 Green growth, not just growth
• Supports businesses embedding sustainability and ESG principles
• Aligned with the UK’s net-zero ambitions, helping SMEs modernize operations
• Encourages energy transition and environmental impact as part of ROI

⚙️ Regional strength meets national ambition
• FDC is Birmingham-based, with a track record of £200M+ invested since 2016
• This marks its second major partnership with the British Business Bank
• Evolution Fund is designed to bridge the funding gap outside London and the Southeast

💡 A long-term bet on real economy businesses
• Supported by West Midlands Pension Fund and public capital
• Not chasing blitz-scale startups—focused on sustainable, grounded returns
• Combines financial firepower with place-based economic strategy

The Evolution Fund is a bold reminder: not every high-growth opportunity wears a hoodie—some wear hard hats.

📊 Powered by V3V Ventures

🧪 GlycoEra: Breaking Boundaries in Autoimmune Protein Degradation

Swiss biotech GlycoEra has secured a $130M Series B led by Novo Holdings to push its extracellular protein degraders into the clinic—tackling autoimmune diseases by selectively clearing harmful antibodies from the bloodstream.

🔬 Precision degradation for chronic conditions
• Lead candidate GE8820 targets IgG4 autoantibodies implicated in diseases like pemphigus and myasthenia gravis
• Uses a bifunctional biologic to direct pathogenic proteins to lysosomes for degradation
• Aims to treat without broad immunosuppression—potentially safer and more selective than current therapies

🧱 Platform with pipeline potential
• “CustomGlycan” tech enables modular design of degraders for different extracellular targets
• Pipeline includes multiple preclinical programs across immunology and inflammation
• Strong IP portfolio rooted in glycoengineering research from ETH Zurich and Roche

💸 Built to scale, backed to last
• $130M round brings in Catalio, LifeArc, QIA, and others alongside existing VCs like Sofinnova and 5AM
• Funds will drive GE8820 into human trials and advance a second program
• Adds seasoned execs and investors to accelerate development and BD efforts

🌍 Degraders beyond oncology
• Most protein degrader companies focus on intracellular cancer targets—GlycoEra is expanding the field
• Extracellular targets could open doors to treating a broader range of chronic, systemic diseases
• Strategy aligned with long-term trends in autoimmune disease R&D and precision biologics

GlycoEra is carving a niche where few have ventured: degrading disease-causing proteins outside the cell—before they trigger immune chaos.

📊 Powered by V3V Ventures

🩺 Exo: Samsung’s Bet on AI-Powered Handheld Ultrasound

Samsung Ventures is reportedly in talks to invest up to $100M in Exo, a California-based startup reimagining ultrasound through AI and silicon innovation—positioning itself at the frontier of point-of-care diagnostics.

🧠 Smarter scans in the palm of your hand
• Exo Iris: A handheld device that replaces multiple traditional ultrasound probes
• Embedded AI: FDA-cleared “SweepAI” offers real-time diagnostic insights—even offline
• Focus: Rapid triage and diagnosis of heart failure, pneumonia, and other critical conditions

🧰 More than hardware: streamlining clinical workflows
• Exo Works: Software suite for image management, documentation, and EMR integration
• Designed for emergency departments, urgent care, and outpatient clinics
• Aims to reduce bottlenecks in traditional radiology and improve access

🤝 Samsung deepens its digital health push
• Talks include potential manufacturing and distribution partnership with Samsung Medison
• Follows Samsung’s $92M acquisition of Sonio (AI for prenatal ultrasound)
• Part of a broader push into diagnostic imaging, wearables, and smart health platforms

📊 A fast-growing medtech scaleup
• $320M+ raised to date from BlackRock, Intel Capital, Sony Innovation Fund, and others
• $220M Series C in 2021; new round led by Sands Capital and Qubed Capital
• Targeting broad international expansion with fresh capital

Samsung’s potential investment signals rising momentum in AI-driven diagnostics—shrinking machines, slashing delays, and scaling precision imaging to frontline care.

📊 Powered by V3V Ventures